Adjusting for regression toward the mean when variables are normally distributed

Statistical Methods in Medical Research

Volumn 6, Issue 2, 1997, Pages 129-146

  Lin, H M ^a   Hughes, M D ^b,c  

^a UNITED NETWORK FOR ORGAN SHARING   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIHYPERTENSIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOMETRY; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN; HYPERTENSION; IMMUNOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIHYPERTENSIVE AGENTS; BIOMETRY; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; HYPERTENSION; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS;

EID: 0031158463     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/096228029700600204     Document Type: Article

References (17)

1. Galton F. Regression towards mediocrity in hereditary stature. Journal of the Anthropological Institute 1886; 15: 246-63.
2. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. American Journal of Epidemiology 1976; 104: 493-98.
3. Cohen AC. Restriction and selection in samples from bivariate normal distributions. Journal of the American Statistical Association 1955; 50: 884-93.
4. Senn SJ, Brown RA. Estimating treatment effects in clinical trials subject to regression to the mean. Biometrics 1985; 41: 555-59.
5. Senn SJ, Brown RA. Maximum likelihood estimation of treatment effects for samples subject to regression to the mean. Communications in Statistics 1989; 18: 3389-406.
6. Chen S, Cox C. Use of baseline data for estimation of treatment effects in the presence of regression to the mean. Biometrics 1992; 48: 593-98.
7. James KE. Regression toward the mean in uncontrolled clinical trials. Biometrics 1973; 29: 121-30.
8. Curnow RN. Correcting for regression in assessing the response to treatment in a selected population. Statistics in Medicine 1987; 6:113-17.
9. Mee RW, Chua TC. Regression toward the mean and the paired sample t test. Journal of the American Statistical Association 1991; 45: 39-42.
10. George V, Johnson WD, Shahane A et al. Testing for treatment effect in the presence of regression toward the mean. Biometrics 1997; 53: 49-59.
11. Gardner MJ, Heady JA. Some effects of within- person variability in epidemiological studies. Journal of Chronic Disease 1973; 26: 781-95.
12. Wilson PD, Hebel JR, Sherwin R. Screening and diagnosis when within-individual observations are Markov-dependent. Biometrics 1981; 37: 553-65.
13. Lin HM, Hughes MD. Use of historical marker data for assessing treatment effects in phase I/ II trials when subject selection is determined by baseline marker level. Biometrics 1995; 51: 1053-63.
14. Lin HM, Hughes MD. Assessing treatment changes on a longitudinal marker of disease in uncontrolled studies. Statistics in Medicine 1996; 15: 2053-67.
15. Lin HM, Hughes MD. Assessing the effects of interventions using longitudinal data with samples subject to selection. Biometrics 1997; 53: in press.
16. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982; 38: 963-74.
17. Ederer F. Serum cholesterol: effects of diet and regression toward the mean. Journal of Chronic Disease 1972; 25: 277-89.